Thromboxane receptor signalling in renal ischemia reperfusion injury

Free Radical Research

Volumn 45, Issue 6, 2011, Pages 699-706

  Snoeijs, Maarten G J ^a   Hoogland, Pieter R ^a   Boonen, Bas ^a   Coffman, Thomas M ^b   Peutz Kootstra, Carine J ^a   Buurman, Wim A ^a   Van Heurn, L W Ernest ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; F2 isoprostanes; ischemia reperfusion injury; thromboxane A2; TP receptor

Indexed keywords

ISOPROSTANE DERIVATIVE; MALONALDEHYDE; MYELOPEROXIDASE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; THROMBOXANE B2;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; IN VIVO STUDY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PLASMA CLEARANCE; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; URINE CULTURE;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; BLOOD UREA NITROGEN; CREATINE; F2-ISOPROSTANES; GENE DELETION; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, THROMBOXANE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; THROMBOXANE A2;

MUS;

EID: 79959450402     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.571686     Document Type: Article

References (36)

1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16: 3365-3370. (Pubitemid 46179340)
2. Yarlagadda SG, Coca SG, Formica RN, Jr, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009;24:1039-1047.
3. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74:1156-1164. (Pubitemid 15206810)
4. Koyama I, Bulkley GB, Williams GM, Im MJ. The role of oxygen free radicals in mediating the reperfusion injury of cold-preserved ischemic kidneys. Transplantation 1985;40: 590-595. (Pubitemid 16207180)
5. Baker GL, Corry RJ, Autor AP. Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase. Ann Surg 1985;202:628-641. (Pubitemid 16245048)
6. Stafforini DM, Sheller JR, Blackwell TS, Sapirstein A, Yull FE, McIntyre TM, Bonventre JV, Prescott SM, Roberts LJ, 2nd. Release of free F2-isoprostanes from esterifi ed phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem 2006;281:4616-4623. (Pubitemid 43847720)
7. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ, 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383-9387. (Pubitemid 120030630)
8. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, 2nd, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005;38:698-710. (Pubitemid 40249740)
9. Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ, 2nd, Hoover RL, Badr KF. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest 1992;90: 136-141.
10. Khasawneh FT, Huang JS, Mir F, Srinivasan S, Tiruppathi C, Le Breton GC. Characterization of isoprostane signaling: evidence for a unique coordination profi le of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets. Biochem Pharmacol 2008;75:2301-2315.
11. Krier JD, Rodriguez-Porcel M, Best PJ, Romero JC, Lerman A, Lerman LO. Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs. Am J Physiol Regul Integr Comp Physiol 2002;283:303-308.
12. Alejandro V, Scandling JD, Jr, Sibley RK, Dafoe D, Alfrey E, Deen W, Myers BD. Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. J Clin Invest 1995;95:820-831.
13. Audoly LP, Rocca B, Fabre JE, Koller BH, Thomas D, Loeb AL, Coffman TM, FitzGerald GA. Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo . Circulation 2000;101:2833-2840. (Pubitemid 30396015)
14. Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, Hoffman M, Smithies O, Koller BH, Coffman TM. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 1998;102: 1994-2001. (Pubitemid 29001846)
15. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005;115: 2894-2903. (Pubitemid 41434417)
16. Kelly KJ, Sandoval RM, Dunn KW, Molitoris BA, Dagher PC. A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis. Am J Physiol Cell Physiol 2003;284:1309-1318.
17. Thurman JM. Triggers of inflammation after renal ischemia/ reperfusion. Clin Immunol 2007;123:7-13. (Pubitemid 46401502)
18. Kelly KJ, Williams WW, Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV. Intercellular adhesion molecule-1-defi cient mice are protected against ischemic renal injury. J Clin Invest 1996;97:1056-1063. (Pubitemid 26070586)
19. Daemen MA, van ' t Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999;104:541-549.
20. Kramer HJ, Mohaupt MG, Pinoli F, Backer A, Meyer-Lehnert H, Schlebusch H. Effects of thromboxane A2 receptor blockade on oliguric ischemic acute renal failure in conscious rats. J Am Soc Nephrol 1993;4:50-57.
21. Cracowski JL, Stanke-Labesque F, Devillier P, Chavanon O, Hunt M, Souvignet C, Bessard G. Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)]. Eur J Pharmacol 2000;397: 161-168. (Pubitemid 30323822)
22. Gardan B, Cracowski JL, Sessa C, Hunt M, Stanke-Labesque F, Devillier P, Bessard G. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins. J Cardiovasc Pharmacol 2000;35:729-734. (Pubitemid 30253613)
23. Benndorf RA, Schwedhelm E, Gnann A, Taheri R, Kom G, Didie M, Steenpass A, Ergun S, Boger RH. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis. Circ Res 2008;103:1037-1046.
24. Tang M, Cyrus T, Yao Y, Vocun L, Pratico D. Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E-and LDL receptor-defi cient mice. Circulation 2005;112:2867-2874. (Pubitemid 41641682)
25. Minuz P, Andrioli G, Degan M, Gaino S, Ortolani R, Tommasoli R, Zuliani V, Lechi A, Lechi C. The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 1998;18:1248-1256. (Pubitemid 28376181)
26. Iuliano L, Pratico D, Greco C, Mangieri E, Scibilia G, FitzGerald GA, Violi F. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 2001;37:76-80. (Pubitemid 32051721)
27. Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K. Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization. J Clin Invest 1995;96:657-664.
28. Mannon RB, Coffman TM, Mannon PJ. Distribution of binding sites for thromboxane A2 in the mouse kidney. Am J Physiol 1996;271:1131-1138.
29. Brown GP, Venuto RC. Thromboxane receptors in human kidney tissues. Prostaglandins Other Lipid Mediat 1999;57: 179-188. (Pubitemid 29323623)
30. Boffa JJ, Just A, Coffman TM, Arendshorst WJ. Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice. J Am Soc Nephrol 2004;15:2358-2365. (Pubitemid 39159335)
31. Kawada N, Dennehy K, Solis G, Modlinger P, Hamel R, Kawada JT, Aslam S, Moriyama T, Imai E, Welch WJ, Wilcox CS. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol 2004;287:753-759.
32. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009;47:469-484.
33. Lelcuk S, Alexander F, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Prostacyclin and thromboxane A2 moderate postischemic renal failure. Surgery 1985;98:207-212. (Pubitemid 16161453)
34. Nowak J, FitzGerald GA. Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. J Clin Invest 1989;83:380-385. (Pubitemid 19061155)
35. Klausner JM, Paterson IS, Kobzik L, Rodzen C, Valeri CR, Shepro D, Hechtman HB. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited. Ann Surg 1989;209:219-224. (Pubitemid 19055324)
36. Narumiya S, FitzGerald GA. Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 2001;108:25-30. (Pubitemid 32634917)